GL1X · GenesisL1 explorer

MolNFT v1 · #108561 · protein

Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor

4WAG · Phosphatidylinositol 4-kinase BETA,PHOSPHATIDYLINOSITOL 4…: “Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor”. X-ray diffraction, 1 ligand (3K7), 5 pockets (best druggability 0.70). MolNFT v1 #108561 on…

PDB
4WAG
Type
protein
Length
462 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4-kinase BETA,PHOSPHATIDYLINOSITOL 4- kinase beta
EC
2.7.1.67
UniProt
Q9UBF8
Ligands
3K7
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4-kinase BETA,PHOSPHATIDYLINOSITOL 4- kinase beta (EC 2.7.1.67)protein46250% helix, 8% strandQ9UBF8

Ligands and binding sites

  • 3K7 · 6-chloro-3-(3,4-dimethoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15990.700.7956empty
24050.610.76413K7
31320.460.7721empty
4590.310.7616empty
5600.290.7415empty

Compared structures

  • 4WAG · Phosphatidylinositol 4-kinase III beta crystallized with MI103 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UBF8 · AlphaFold monomer V2.0 prediction for phosphatidylinositol 4-kinase beta (Q9UBF8) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.